Drug Profile
RC 591
Alternative Names: PNS; Polymeric nasal spray - Johnson & Johnson; RC-591Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Johnson & Johnson; McNeil-PPC
- Class Antivirals
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Common cold
Most Recent Events
- 08 May 2012 McNeil completes a phase II trial in Common cold in United Kingdom (NCT01488604)
- 13 Jan 2012 Phase-II clinical trials in Common cold in United Kingdom (Intranasal)